{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24(1)"],"submitter":["Abu Shtaya A"],"funding":["Tel Aviv University"],"pubmed_abstract":["Deciphering the spectrum and founder disease-causing variants (DCVs) in specific populations can shape and facilitate the diagnostic process of Lynch Syndrome (LS). The aim of this report was to comprehensively update on the genetic landscape of LS in the ethnically diverse Israeli-Jewish population. The cohort included 1080 carriers from 588 families; some from underrepresented, understudied Israeli ethnic groups recruited from 8 genetic institutes and high-risk clinics throughout the country. Variant classification was performed according to the American College of Medical Genetics criteria. A total of 157 DCVs were identified, 12 are reported here for the first time, and 9 reclassified. MSH2 DCVs were identified in 286 families (49%). Most DCVs (125/157, 80%) were noted in one or two fa"],"journal":["Familial cancer"],"pagination":["6"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11567984"],"repository":["biostudies-literature"],"pubmed_title":["The genetic landscape of Lynch syndrome in the Israeli population."],"pmcid":["PMC11567984"],"pubmed_authors":["Samra NN","Lieberman S","Abu Shtaya A","Nathan SN","Goldberg Y","Shalev SA","Mordechai S","Rafid SS","Vinkler C","Hagari-Bechar O","Bazak L","Levi GR","Douiev L","Half E","Lidzbarsky G","Segol O","Katz L","Abu-Freha N","Mattar S","Kalis ML","Barhom SF","Peretz LP","Barzily-Rokni M","Laish I","Levi Z","Friedman E","Peretz-Yablonski T","Bernstein-Molho R","Salmon LB","Bruchim R","Kedar I","Schechter M"],"additional_accession":[]},"is_claimable":false,"name":"The genetic landscape of Lynch syndrome in the Israeli population.","description":"Deciphering the spectrum and founder disease-causing variants (DCVs) in specific populations can shape and facilitate the diagnostic process of Lynch Syndrome (LS). The aim of this report was to comprehensively update on the genetic landscape of LS in the ethnically diverse Israeli-Jewish population. The cohort included 1080 carriers from 588 families; some from underrepresented, understudied Israeli ethnic groups recruited from 8 genetic institutes and high-risk clinics throughout the country. Variant classification was performed according to the American College of Medical Genetics criteria. A total of 157 DCVs were identified, 12 are reported here for the first time, and 9 reclassified. MSH2 DCVs were identified in 286 families (49%). Most DCVs (125/157, 80%) were noted in one or two fa","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-04-23T03:23:57.882Z","creation":"2025-04-06T22:42:37.583Z"},"accession":"S-EPMC11567984","cross_references":{"pubmed":["39546165"],"doi":["10.1007/s10689-024-00432-w"]}}